Indications and methods for therapeutic apheresis.
Technological advancements in the biomedical field have recently afforded the clinician opportunities to safely treat disease processes that previously defied conventional medicine. Therapeutic apheresis is one such application of these advancements and offers potential benefit to patients suffering from various hematological, renal, rheumatic, and neuromuscular disorders. Research is continually being done to clearly define the role of this new therapy. New protocols are continually being developed and evaluated in the attempt to find out and control the variables necessary to nesure that each disease process is treated in the most effective manner possible.
D001327:Autoimmune Diseases / Q000628:therapy; D001777:Blood Coagulation; D001803:Blood Transfusion; D001809:Blood Viscosity; D002469:Cell Separation; D005434:Flow Cytometry; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy; D007937:Leukapheresis; D007938:Leukemia / Q000628:therapy; D009157:Myasthenia Gravis / Q000628:therapy; D010951:Plasma Exchange